Translation inhibitor PDCD4 promotes CD8+ T cell proliferation during antiviral response

Abstract

Abstract CD8+ T cell clonal expansion is critical for controlling intracellular infections and tumors. Thus, unravelling the mechanisms that regulate CD8+ T cell proliferation are imperative to improve vaccine design and immunotherapy. However, the molecular mechanisms that govern CD8+ T cell proliferation are still not fully understood. PDCD4 (Programmed cell death 4) was shown to inhibit translation by sequestering mRNA helicase eIF4A, which leads to translation inhibition of genes involved in cell proliferation. Despite the well-characterized anti-proliferative role of PDCD4, our studies suggest that PDCD4 promotes CD8+ T cell proliferation during the expansion phase of acute LCMV infection. We find that PDCD4 over-expressed Ag-specific CD8+ T cells have higher proliferation rate which leads to increased cell number compared to control Ag-specific CD8+ T cells. Consistent with the over-expression results, PDCD4 knocking-down Ag-specific CD8+ T cells undergo less cell proliferation, resulting in reduced clonal expansion compared to controls. Interestingly, contrary to the paradigm that increased proliferation generates more short-lived effector cells, CD8+ T cell proliferation mediated by PDCD4 does not skew the differentiation of short-lived and memory precursor effector cells. This PDCD4 mediated CD8+ T cell proliferation is also confirmed by over-expression of a constitutively active form of PDCD4 which resists degradation by CD8+ T cell endogenous ubiquitin pathway. In conclusion, our work has identified a novel pro-proliferative role of PDCD4 during CD8+ T cell response. Supported by grants from NIH (R01 AI139675)